Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
NCT06608966 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310
Last updated 2025-04-25
Summary
The goal of this multi-site clinical trial is to determine the effectiveness of two components of a web-based intervention (Epilepsy Journey) to improve executive functioning in adolescents with epilepsy. The two components include web-based modules and problem-solving telehealth sessions with a therapist focused on executive functioning. This trial aims to answer the following questions:
1. Which components of Epilepsy Journey (web-based modules or telehealth sessions with a therapist) are essential for improving executive functioning in adolescents with epilepsy?
2. Which components of Epilepsy Journey (web-based modules or telehealth sessions with a therapist) are essential for improving quality of life in adolescents with epilepsy?
Participants will be randomly assigned to one of four groups: 1) Epilepsy Journey web-based modules and telehealth sessions, 2) Epilepsy Journey web-based modules only, 3) telehealth sessions with a therapist only, or 4) treatment as usual.
Participants will:
* Independently review Epilepsy Journey web-based modules focused on executive functioning skills (\~15-30 minutes) and/or have weekly telehealth sessions (\~30-45 minutes) with a therapist for 14 weeks.
* Complete measures of executive functioning (parent and teen-report) and quality of life (teen-report) at the start of the study, 14-, 26-, and 66- weeks after randomization. The NIH toolbox will be completed at the start of the study and 26-weeks after randomization. Additional measures will also be collected.
Conditions
- Epilepsy in Children
- Executive Dysfunction
Interventions
- BEHAVIORAL
-
Epilepsy Journey web-based modules
Participants assigned to Epilepsy Journey modules will independently review web-based EJ modules focused on executive functioning skills. The modules cover 10 topic areas: Positive Thoughts, Problem-Solving, Initiation, Working Memory, Monitoring, Inhibition, Emotional Control, Organization and Planning, Sleep/Stress, and a Wrap-Up. Participants will complete 10 modules (\~15-30 minutes each session) within a 14-week time frame. The goal is to complete one module per week.
- BEHAVIORAL
-
Telehealth with a therapist
Therapist will cover 10 areas of executive functioning during telehealth sessions, including Positive Thoughts, Problem-Solving, Initiation, Working Memory, Monitoring, Inhibition, Emotional Control, Organization and Planning, Sleep/Stress, and a Wrap-Up. Telehealth sessions with a therapist will occur via HIPAA-compliant videoconference (e.g. Microsoft Teams) each week ideally over the course of 14 weeks.
Sponsors & Collaborators
-
Medical University of South Carolina
collaborator OTHER -
Children's Hospital of Orange County
collaborator OTHER -
University of Georgia
collaborator OTHER -
University of Iowa
collaborator OTHER -
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH -
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
Avani Modi, Ph.D. · Children's Hospital Medical Center, Cincinnati
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 13 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-11
- Primary Completion
- 2028-10-31
- Completion
- 2029-01-31
Countries
- United States
Study Locations
More Related Trials
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Clinic-based and Technology-Supported Sleep Intervention for Pediatric Epilepsy
NCT06661759 ·Status: RECRUITING ·Phase: NA
-
Managing Epilepsy Well- WebEase Project
NCT00726076 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
NCT01397968 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy
NCT00236743 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
NCT00266604 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
NCT00236704 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Status Epilepticus Treatment Times
NCT06194747 ·Status: RECRUITING ·Phase: NA
-
Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures
NCT01118455 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
NCT00236756 ·Status: COMPLETED ·Phase: PHASE3
-
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
NCT03336242 ·Status: TERMINATED ·Phase: PHASE2
-
Bridging the Childhood Epilepsy Treatment Gap in Africa
NCT04290975 ·Status: COMPLETED ·Phase: NA
-
Behavioral and Educational Tools to Improve Epilepsy Care
NCT02646631 ·Status: COMPLETED ·Phase: NA
-
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
NCT00235755 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Youth Epilepsy and Successful Self-Management Intervention
NCT03639233 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure
NCT00230698 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
NCT01866111 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy
NCT00266591 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
NCT05954182 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Efficacy of a Mobile Epilepsy Education Application
NCT06402526 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301 ·Status: COMPLETED ·Phase: PHASE2
-
PRX-00023 Therapy in Localization-Related Epilepsy
NCT01281956 ·Status: TERMINATED ·Phase: PHASE2
-
Transition From Pediatric to Adult Epilepsy Care
NCT06778772 ·Status: RECRUITING